title: In vivo X-ray imaging reveals improved airway surface hydration after a therapy designed for cystic fibrosis.
authors.affiliation: 1 Monash University Clayton, Victoria, Australia.
authors.forename: Kaye S
authors.initials: KS
authors.lastname: Morgan
authors.forename: Martin
authors.initials: M
authors.lastname: Donnelley
authors.forename: Nigel
authors.initials: N
authors.lastname: Farrow
authors.forename: Andreas
authors.initials: A
authors.lastname: Fouras
authors.forename: Naoto
authors.initials: N
authors.lastname: Yagi
authors.forename: Yoshio
authors.initials: Y
authors.lastname: Suzuki
authors.forename: Akihisa
authors.initials: A
authors.lastname: Takeuchi
authors.forename: Kentaro
authors.initials: K
authors.lastname: Uesugi
authors.forename: Richard C
authors.initials: RC
authors.lastname: Boucher
authors.forename: Karen K W
authors.initials: KK
authors.lastname: Siu
authors.forename: David W
authors.initials: DW
authors.lastname: Parsons
mesh_terms: D000818:Animals; D003550:Cystic Fibrosis / Q000000981:diagnostic imaging* / Q000188:drug therapy*; D004195:Disease Models, Animal; D062686:Epithelial Sodium Channel Blockers / Q000627:therapeutic use*; D007552:Isotonic Solutions / Q000008:administration & dosage; D051379:Mice; D008810:Mice, Inbred C57BL; D009079:Mucociliary Clearance / Q000187:drug effects*; D011859:Radiography; D012965:Sodium Chloride / Q000008:administration & dosage; D014132:Trachea / Q000000981:diagnostic imaging*
chemical_list: D062686:Epithelial Sodium Channel Blockers; D007552:Isotonic Solutions; D012965:Sodium Chloride